Overview
Overview
Precisio Biotix Therapeutics (the "Company" or "Precisio") is a US incorporated industry leader in precision antibacterial biological solutions; specifically, the identification and development of lysin, amurin, and phage products and related delivery technologies. These solutions combat bacterial infections or difficult to treat bacterial issues and address large unmet medical needs.
Antibiotics and chemical treatments are increasingly less effective as bacteria continue to develop antimicrobial resistance ("AMR"). The market that Precisio seeks to address includes AMR infections (at least US$55B global need) and other difficult to treat bacterial issues (at least $40B global need).
The Zeus™-LysiThru™ Platform is an industry-leading lysin high-throughput discovery, optimization, and screening system. The systems are capable of rapidly creating new and highly active lead lysins, optimized for human medicinal use, for virtually every Gram-positive and Gram-negative pathogen.
Products created with lysins, amurins, and phages are novel precision solutions to address the declining effectiveness of existing treatments.
The Company has a robust pipeline of commercial products with both Rx and consumer commercial opportunities. Multiple products for different industry segments: Precisio's unique products significantly improve current treatment options, including the areas of:
▪ Rx: Treatments for targeted invasive infections (including blood, lung, prosthetic joint, and vaginal) and topical infections. Emphasis on effectiveness against AMR infections (both Gram-positive and Gram-negative).
▪ OTC: Treatments for targeted topical infections or indications where current treatments perform poorly.
▪ Cosmeceuticals and Consumer Products: Multiple uses of lysins in cosmetics, consumer, and related products. Currently registering a line of staph lysin products in China and Europe as medical devices .
The management team is led by Mark Engel, who has built five successful life science companies, and includes the global leading scientists in the field of lysins, amurins and phages.
